November 6, 2017 / 12:17 PM / 14 days ago

Drugmaker Mylan's revenue drops 2.3 percent

Nov 6 (Reuters) - U.S. drugmaker Mylan NV reported a 2.3 percent decline in third-quarter revenue on Monday, hurt by lower sales in North America.

The company’s net earnings were $88.3 million, or 16 cents per share, in the quarter ended Sept. 30, compared with a loss of $119.8 million, or 23 cents per share, a year earlier.

The year-ago quarter included litigation-related expenses of $558 million.

Total revenue fell to $2.99 billion from $3.06 billion. (Reporting by Tamara Mathias in Bengaluru; Editing by Sriraj Kalluvila)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below